This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


1b9e

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:1b9e.gif|left|200px]]
+
{{Seed}}
 +
[[Image:1b9e.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_1b9e| PDB=1b9e | SCENE= }}
{{STRUCTURE_1b9e| PDB=1b9e | SCENE= }}
-
'''HUMAN INSULIN MUTANT SERB9GLU'''
+
===HUMAN INSULIN MUTANT SERB9GLU===
-
==Overview==
+
<!--
-
The structure of human insulin mutant B9 (Ser--&gt;Glu) was determined by an X-ray crystallographic method at 2.5 A resolution with an R factor of 0.165 under non-crystallographic restraints. The crystals were grown at low pH (&lt;3.8) and belong to the orthorhombic P2(1)2(1)2(1) space group with unit-cell dimensions a = 44.54, b = 46.40, c = 51.85 A and one dimer per asymmetric unit without further aggregation. The structure in this crystal form can be regarded as a model for a discrete insulin dimer and displays the following features compared with the structure of 2Zn insulin. (i) The overall dimer is expanded and more symmetric. The two A chains are about 2 A more distant from each other, while the two B chains are about 0.8 A further apart. Both monomers are more similar to molecule 1 than molecule 2 of the 2Zn insulin dimer. (ii) The dimer structure is stabilized by protonation and neutralization of the carboxyl groups at lower pH and, in addition, by formation of a hydrogen-bond network among the side chains of residues GluB9, HisB13 and HisB10 on the dimer-forming surface of both monomers, resulting from a structural rearrangement. (iii) The B-chain amino-terminal segment is in an open state (O state), i.e. a state different from the well known R and T states found in the insulin hexamer. In the O state, the B-chain N-terminal segment is in an extended conformation and is detached from the rest of the molecule. This conformational state has also been observed in the monomeric crystal structure of despentapeptide (B26-B30) and desheptapeptide (B24-B30) insulin, as well as in the solution structure of an engineered insulin monomer. It suggests that the O state may be the characteristic conformation of insulin in lower aggregation forms and may be relevant to the formation of insulin fibrils. In addition, based on the crystallization process, the smallest possible building blocks of insulin crystal are also discussed.
+
The line below this paragraph, {{ABSTRACT_PUBMED_10489447}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 10489447 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_10489447}}
==About this Structure==
==About this Structure==
Line 28: Line 32:
[[Category: Fast-acting insulin]]
[[Category: Fast-acting insulin]]
[[Category: Hormone]]
[[Category: Hormone]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Fri May 2 11:14:23 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jun 30 18:37:39 2008''

Revision as of 15:37, 30 June 2008

Image:1b9e.png

Template:STRUCTURE 1b9e

HUMAN INSULIN MUTANT SERB9GLU

Template:ABSTRACT PUBMED 10489447

About this Structure

1B9E is a Protein complex structure of sequences from Homo sapiens. Full crystallographic information is available from OCA.

Reference

Structure of an insulin dimer in an orthorhombic crystal: the structure analysis of a human insulin mutant (B9 Ser-->Glu)., Yao ZP, Zeng ZH, Li HM, Zhang Y, Feng YM, Wang DC, Acta Crystallogr D Biol Crystallogr. 1999 Sep;55(Pt 9):1524-32. PMID:10489447

Page seeded by OCA on Mon Jun 30 18:37:39 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/1b9e"
Personal tools